{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:11:09Z","timestamp":1767337869139,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejogrb.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T17:28:25Z","timestamp":1720027705000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome \u2013 A randomized controlled trial"],"prefix":"10.1016","volume":"300","author":[{"given":"Marina","family":"Andavar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Kamaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thangavel","family":"Mahalingam Vijayakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.001_b0005","first-page":"106","article-title":"Diagnosis and treatment of polycystic ovary syndrome","volume":"94","author":"Williams","year":"2016","journal-title":"Fam Physician"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Open Access REVIEW Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/478972","article-title":"Genetic markers of polycystic ovary syndrome: emphasis on insulin resistance","volume":"2014","author":"Shaikh","year":"2014","journal-title":"Int J Med Genet"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0020","first-page":"7624932","article-title":"Genetic variants associated with hyperandrogenemia in PCOS pathophysiology","volume":"2018","author":"Dadachanji","year":"2018","journal-title":"Genet Res Int"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.07.001_b0025","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/humrep\/16.10.2066","article-title":"Clinical, endocrine and metabolic effects of acarbose, an \u03b1-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance","volume":"16","author":"Ciotta","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0030","first-page":"3","article-title":"A review: brief insight into polycystic ovarian syndrome","author":"Bulsara","year":"2021","journal-title":"Endocr Metab Sci"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0035","article-title":"Characteristics of polycystic ovary syndrome throughout life","volume":"14","author":"Louwers","year":"2020","journal-title":"Ther Adv Reprod Health"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2015.01.019","article-title":"Off-label drug use in the treatment of polycystic ovary syndrome","volume":"103","author":"Vitek","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0045","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1177\/1933719118765985","article-title":"Impact of metformin on IVF outcomes in overweight and obese women with polycystic ovary syndrome: a randomized double-blind controlled trial","volume":"26","author":"Abdalmageed","year":"2019","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0050","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.mayocp.2019.06.015","article-title":"Effect of metformin on microvascular endothelial function in polycystic ovary syndrome","volume":"94","author":"Heidari","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40618-021-01691-5","article-title":"The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial","volume":"45","author":"Soldat-Stankovi\u0107","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/cen.13304","article-title":"Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study","volume":"86","author":"Tagliaferri","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0065","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1517\/14656566.2015.1070827","article-title":"Therapeutic potential of \u03b1-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review","volume":"16","author":"Joshi","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/dmrr.2576","article-title":"Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database","volume":"31","author":"Weng","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21197157","article-title":"Altered ovarian inositol ratios may account for pathological steroidogenesis in pcos","volume":"21","author":"Unfer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0080","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/09513590.2020.1810657","article-title":"Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial","volume":"37","author":"Prabhakar","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0085","unstructured":"Weir CB, Jan A. BMI Classification Percentile And Cut Off Points. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/."},{"issue":"3","key":"10.1016\/j.ejogrb.2024.07.001_b0090","first-page":"123","article-title":"Homeostatic model assessment for insulin resistance (HOMA-IR): a better marker for evaluating insulin resistance than fasting insulin in women with polycystic ovarian syndrome","volume":"27","author":"Majid","year":"2017","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0095","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: a review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0100","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5539\/gjhs.v8n9p281","article-title":"Comparing the effect of metformin and acarbose accompanying clomiphene on the successful ovulation induction in infertile women with polycystic ovary syndrome","volume":"8","author":"Rezai","year":"2016","journal-title":"Glob J Health Sci"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humrep\/deh580","article-title":"Comparison of the effects of acabose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome","volume":"20","author":"S\u00f6nmez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09513590.2012.743020","article-title":"Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study","volume":"29","author":"Artini","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijgo.2004.08.015","article-title":"Metformin therapy in women with polycystic ovary syndrome","volume":"87","author":"Aruna","year":"2004","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09513590.2013.860120","article-title":"Comparison between effects of myo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS","volume":"30","author":"Pizzo","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.07.001_b0130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00404-019-05064-5","article-title":"The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole","volume":"299","author":"Pourghasem","year":"2019","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.07.001_b0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0015-0282(00)01675-7","article-title":"Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. n.d","volume":"75","author":"Vandermolen","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0140","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.fertnstert.2007.07.1326","article-title":"Clinical, endocrine, and metabolic effects of acarbose, a \u03b1-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome","volume":"90","author":"Tu\u01e7rul","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/09513590.2015.1101444","article-title":"Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome","volume":"32","author":"Pacchiarotti","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.07.001_b0150","doi-asserted-by":"crossref","first-page":"E1491","DOI":"10.1210\/jc.2013-1865","article-title":"Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome","volume":"98","author":"Rice","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0034-1375676","article-title":"Effects of acarbose on polycystic ovary syndrome: a meta-analysis","volume":"122","author":"Zhang","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.001_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12978-021-01073-3","article-title":"Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies","volume":"18","author":"Merviel","year":"2021","journal-title":"Reprod Health"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.07.001_b0165","first-page":"55","article-title":"Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation","volume":"2","author":"Bertoldo","year":"2014","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.001_b0170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-018-0243-5","article-title":"Comparison of glycemic control and \u03b2-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment","volume":"18","author":"Tao","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09513590.2018.1520827","article-title":"The effect of myoinositol on ovarian blood flows in women with polycystic ovary syndrome","volume":"35","author":"\u00d6zay","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"10.1016\/j.ejogrb.2024.07.001_b0180","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/oxfordjournals.humrep.a019118","article-title":"Acarbose reduces elevated testosterone serum concentrations in hyperinsulinaemic premenopausal women: a pilot study*","volume":"11","author":"Geisth\u00f6vel","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0185","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2265.2008.03260.x","article-title":"A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study","volume":"69","author":"Sathyapalan","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0190","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/jc.2014-2443","article-title":"Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study","volume":"100","author":"Chang","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.001_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40360-023-00706-6","article-title":"The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials","volume":"24","author":"Yousefi","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0205","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1017\/S0007114521001409","article-title":"Myo-inositol improves growth performance and regulates lipid metabolism of juvenile Chinese mitten crab (Eriocheir sinensis) fed different percentage of lipid","volume":"127","author":"Bu","year":"2022","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.07.001_b0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12944-018-0779-4","article-title":"The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Tabrizi","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0215","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1161\/ATVBAHA.120.315708","article-title":"New insight into metformin-induced cholesterol-lowering effect crosstalk between glucose and cholesterol homeostasis via ChREBP (Carbohydrate-responsive element-binding protein)-mediated PCSK9 (proprotein convertase subtilisin\/kexin type 9) regulation","volume":"41","author":"Hu","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0220","article-title":"Alpha-glucosidase inhibitors for type 2 diabetes mellitus","volume":"18","author":"Van de Laar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.07.001_b0225","first-page":"2120","article-title":"Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK\/PI3K\/JNK pathway","volume":"15","author":"Wu","year":"2018","journal-title":"Exp Ther Med"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:07:38Z","timestamp":1762456058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524003361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":45,"alternative-id":["S0301211524003361"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.001","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome \u2013 A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}